Significantly Increased Titer and Productivity Icon
Bioreactor and operon optimization leads to a higher BC yield g/L and faster synthesis rate g/L/h than static culture.
Bacterial Cellulose BC is a high-purity biopolymer used in hydrogels/composites e.g. wound dressings, acoustic membranes. BC production faces challenges including: Low production efficiency titer and productivity in static culture compared to synthetic polymers. The current production relies heavily on high cost of carbon source feedstock typically glucose. Furthermore, it is difficult to control the fiber morphology e.g. porosity, crystallinity during production, limiting material property customization.
CD Biosynsis offers a comprehensive approach to optimize BC bioproduction: Genetic Modification: Overexpress the BC synthesis operon bcsABCD in Komagataeibacter xylinus . This maximizes carbon flux toward cellulose production, increasing yield. We reduce operating costs through Feedstock Engineering: Modify the strain to utilize cheaper feedstocks e.g. crude glycerol, waste molasses by introducing related metabolic pathways, ensuring economic viability. Finally, we address productivity and material control with Bioreactor Design: Implement rotating or agitated culture systems to increase surface area and enhance oxygen transfer for higher yield and control over the resulting fiber structure.
Get a QuoteCommercial BC production faces these key challenges:
A successful solution requires maximizing BC flux, minimizing feedstock costs, and optimizing the bioreactor for enhanced gas transfer.
CD Biosynsis utilizes comprehensive engineering strategies to optimize BC production:
BC Operon Overexpression
We overexpress all four genes bcsABCD of the BC synthesis operon in K. xylinus, eliminating enzymatic bottlenecks and maximizing conversion efficiency from glucose to BC.
Low-Cost Feedstock Utilization
We modify the host strain to effectively catabolize industrial byproducts such as crude glycerol or waste molasses by introducing necessary metabolic pathways and optimizing carbon partitioning.
Bioreactor System Design
We implement rotating disk or agitated tank bioreactor designs to enhance oxygen transfer, increase the available surface area, and control fiber morphology for higher productivity and customization.
Morphology Control Engineering
We modify the expression of accessory genes e.g. bcsC or use specific fermentation additives to control the crystallinity and porosity of the resulting BC material, tailoring it for specific hydrogel or composite applications. [Image of High Conversion Efficiency Icon]
This systematic optimization ensures high BC titer, lower production costs, and customized material properties.
Our BC engineering service is dedicated to pursuing the following production goals:
Significantly Increased Titer and Productivity Icon
Bioreactor and operon optimization leads to a higher BC yield g/L and faster synthesis rate g/L/h than static culture.
Reduced Feedstock Cost Icon
Strain utilization of waste streams crude glycerol, molasses significantly lowers raw material expenditure. [Image of Cost Reduction Icon]
Customized Fiber Morphology Control Icon
Optimized agitation and genetic tuning allow precise control over BC structure porosity, crystallinity for specific applications.
Enhanced Oxygen Transfer Efficiency Icon
Rotating bioreactor design solves oxygen limitation in the obligate aerobe K. xylinus, enhancing cell viability and synthesis.
Biocompatible and High-Purity Product Icon
BC produced is inherently pure and provides excellent biocompatibility for use in medical and food-grade applications.
We deliver an economically feasible and highly versatile platform for BC production.
Our BC strain and process engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a high-yield, low-cost BC supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is BC production efficiency low in static culture ?
In static culture, Komagataeibacter xylinus grows only at the liquid-air interface, forming a thick cellulose pellicle. This growth is severely limited by the available surface area and the poor transfer of oxygen to the cells submerged beneath the pellicle. This physical limitation results in low titer BC mass per culture volume and low productivity.
How does feedstock engineering reduce BC production cost?
Conventional BC production relies on expensive pure glucose as the carbon source. Feedstock engineering modifies K. xylinus to metabolize cheap industrial waste streams e.g. crude glycerol from biodiesel production or waste molasses. By utilizing these low-cost alternative substrates, the raw material cost, which is the major economic bottleneck, is significantly reduced.
What is the role of the bcsABCD operon ?
The bcsABCD operon is the core genetic cluster responsible for BC synthesis. It encodes the BC synthase complex and related regulatory proteins. Overexpression of this entire operon ensures that the cell has ample machinery to rapidly convert the central carbon precursor UDP-glucose into cellulose chains, thereby maximizing metabolic flux toward the desired product.
How do agitated bioreactors affect BC morphology and yield?
Agitated bioreactors, such as stirred tanks or rotating biocells, increase oxygen transfer and allow the K. xylinus strain to grow in the liquid phase, boosting overall yield. Importantly, the shear stress from agitation prevents the formation of thick static pellicles, resulting in dispersed, fine BC fibers or granules. This change in morphology allows for easier downstream processing and fine-tuning of material properties like surface area and porosity.
What is the estimated project timeline?
A comprehensive BC engineering project involving operon overexpression, feedstock utilization modification, and bioreactor process optimization typically requires 28-36 weeks for final strain delivery and high-productivity validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.